Author Question: Name two analytes that can be measured immunologically, and list two instruments that currently use ... (Read 108 times)

amal

  • Hero Member
  • *****
  • Posts: 572
Name two analytes that can be measured immunologically, and list two instruments that currently use this method.
 
  What will be an ideal response?

Question 2

Which of the following is considered a drawback of immunophenotyping a suspected acute leukemia?
 
  a. AML NOC
  b. Lineage heterogeneity
  c. Lack of sensitivity
  d. Lack of specificity



dmurph1496

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

Answer: Two analytes: D-dimer and VWF
Two analyzers: Trinity Biotech AMAX destiny plus (D-dimer) and Diagnostica Stago STA compact (vWF)

Answer to Question 2

Correct Answer: B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

IgA antibodies protect body surfaces exposed to outside foreign substances. IgG antibodies are found in all body fluids. IgM antibodies are the first type of antibody made in response to an infection. IgE antibody levels are often high in people with allergies. IgD antibodies are found in tissues lining the abdomen and chest.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

For a complete list of videos, visit our video library